Related Experiment Video
Updated: Aug 12, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Status Dystonicus: An Updated Review on Diagnosis, Pathophysiology, and Management
Vedang N Desai1, Arunav Garg, Arnesh Bhattacharya
1Department of Neurology, Gobind Ballabh Pant Institute of Postgraduate Medical Education and Research, New Delhi, India.
Abstract:
Status dystonicus (SD), also called dystonic storm or dystonic crisis historically, represents a rare and life-threatening exacerbation of dystonia characterized by continuous (tonic) or phasic rapidly recurring dystonic spasms. Common triggers include infections, abrupt changes in medication, and metabolic stress, among others, and necessitate early recognition with multidisciplinary management to prevent multisystemic failure or dysfunction. SD arises in patients with generalized dystonia, more commonly in those with secondary causes, and is associated with basal ganglia dysfunction and predominantly dopaminergic disturbances. The Dystonia Severity Action Plan is a widely accepted staging tool that requires bedside assessment and helps inform therapeutic decisions and intervention levels. Management principles center on identifying and removing triggers, optimizing sedation and airway management, and administering disease-specific therapies. The review aims to provide an overview of the clinical spectrum, the physiological basis, commonly described precipitating factors, and updated management strategies for SD, highlighting a practical approach to the early identification of the syndrome and the bundling of care. A narrative review of peer-reviewed literature from PubMed and Scopus databases was conducted, with emphasis on publications covering etiopathogenesis, risk factors, clinical grading systems, therapeutic options, and outcomes. Key consensus guidelines and case series were appraised. It is evident that early diagnosis and triage, with adequate management, are key to improving survival and neurological outcomes in SD. Adoption of standardized clinical pathways and multicenter data reports will help improve understanding of SD's natural history, clinical evaluation, and therapeutic efficacy across different etiologies.
More Related Videos
08:25Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans
Published on: May 19, 2016
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Related Concept Videos
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics
Parkinson's Disease: Overview
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias VII: Nursing Management of Dysrhythmias
Alterations in Muscle Tone ll